3 big yielders I’d buy and hold for the next 5 years

Royston Wild runs the rule over three London-quoted dividend heroes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With data from the housing industry continuing to surpass expectations, I reckon Taylor Wimpey (LSE: TW) remains a great dividend stock to buy and hang onto well into the future.

Latest Bank of England data showed mortgage approval for property purchases galloping to 11-month highs in January, up 2.4% from December levels, to 69,928, again confounding predictions of a slump in homebuyer appetite.

And Taylor Wimpey itself lauded the strength of the domestic homes market this week. The builder commented that “UK housing market fundamentals remain good with strong customer confidence in our core geographies,” adding that “the market is underpinned by a competitive mortgage market and low interest rates.”

Despite fresh rhetoric from the government in the form of a recent white paper, hard action to address the country’s massive housing imbalance remains elusive, and this should continue to power shareholder returns at the likes of Taylor Wimpey.

With earnings therefore expected to keep rising at the firm, the City has chalked-in dividends of 13.8p and 14.9p per share in 2017 and 2018 respectively, yielding 7.5% and 8%. I reckon the Taylor Wimpey should be on the radar of all serious dividend searchers.

The perfect payout pill?

The exceptional progress of GlaxoSmithKline’s (LSE: GSK) R&D teams convinces me that the pharma ace should deliver increasingly-handsome dividends in the years to come.

The company has kept the dividend locked at 80p per share since 2014 as it has invested heavily in its product pipeline and tackled the problems of critical patent expirations. And the City expects GlaxoSmithKline to make good on its pledge to keep payouts around this level until the end of this year. This creates a bumper 4.8% yield.

And as the firm’s suite of new earnings drivers flies off the shelves — new product sales rocketed to £4.5bn during 2016 — the abacus bashers expect GlaxoSmithKline to get dividends moving higher again from 2018. An 80.3p per share reward is currently forecast, also yielding 4.8%.

And with it expecting test data on between 20 to 30 assets by the close of next year alone, I reckon the groundwork could be laid for spectacular earnings, and consequently dividend growth, further down the line.

Star in space

I also reckon Big Yellow Group (LSE: BYG) should keep churning out exceptional dividends as occupancy rates at its storage sites rise.

The business saw like-for-like revenues edge 5% higher during October-December, with demand for its lock-ups picking up following a difficult start to the quarter. While Big Yellow commented in January that “significant uncertainties remain around the UK’s economic outlook,” the company’s bias towards the South East and London should protect it from the worst of any bumpiness. Indeed, just under half of the firm’s facilities can be found within the M25.

The City certainly expects its rich record of profits growth to keep rolling and has consequently chalked-in dividends of 27.6p per share for the year to March 2017 and 30.1p for fiscal 2018. These figures yield 3.8% and 4.1% respectively, and I reckon the space star is in great shape to keep throwing out market-beating rewards.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman hand stacking up arrow on wooden block cubes
Growth Shares

Why I think the HSBC share price could hit 2,000p by December

Jon Smith explains why the HSBC share price could be primed to rally for the rest of the year, despite…

Read more »

Elevated view over city of London skyline
Investing Articles

£15,000 invested in UK shares a decade ago is now worth…

How have UK shares performed in recent years? That depends which ones you have in mind, as our writer explains.…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

3 FTSE shares with many years of consecutive dividend growth

Paul Summers picks out a selection of FTSE shares that have offered passive income seekers consistency for quite a long…

Read more »

piggy bank, searching with binoculars
Investing Articles

Prediction: Diageo shares could soar in the next 5 years if this happens…

Diageo shares have been in the doldrums for some years now. What on earth could waken this FTSE 100 dud…

Read more »

Investing Articles

With a P/E of 5.9 is this a once-in-a-decade opportunity to buy dirt-cheap easyJet shares?

Today marks a fresh low for easyJet shares, which are falling on a disappointing set of first-half results. Harvey Jones…

Read more »

Investing Articles

Think the soaring Tesco share price is too good to be true? Read this…

The Tesco share price keeps climbing. It's up again today, following a positive set of results, but Harvey Jones says…

Read more »

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

BAE Systems shares are up 274% in 46 months. And I reckon there could be more to come

Our writer’s been learning about the state of Britain’s defence forces. And he thinks it could be good news for…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

5 years ago, £5,000 bought 218 Greggs shares. How many would it buy now?

Greggs sells around 150m sausage rolls every year. But have those who bought the baker’s shares in April 2021 made…

Read more »